Fund Rationale: Lion Global Infinity US 500 Stock Index Fund

Lion Global Infinity US 500 Stock Index Fund
SGD Retail Accumulation Shares (ISIN: SG9999003289)

Fund Manager Page

Endowus has selected the LionGlobal Infinity Global Stock Index Fund as it allows for broad exposure to large and mid-cap companies in the United States, and gives investors, including CPF investors, the access to a low-cost, diversified portfolio of US equities. 

-----------------------------------

Key Information

Fund Objective: Aims for medium to long-term capital appreciation by following the performance of the US stock market through investment as a feeder fund in the Vanguard® U.S. 500 Stock Index Fund.

Suitability: Investors who are seeking to maximise long-term total return, have a long-term investment horizon, and understand that the principal of the Fund will be at risk.

Cost: 

LionGlobal_Infinity_US_500_Stock_Index_Fund_Cost.png

* Total Fund-level Fees include fund management fee of 0.475%.

** Endowus does not charge a preliminary sales charge or any other additional fees, other than the all-in Endowus Access Fee. 

Fund Characteristics

Fund Inception:  31 May 2000

Share Class Inception: 31 May 2000
Benchmark: S&P 500 Index

Fund AUM: SGD 232m

Source: MorningStar as of 30 April 2021. Please refer to the FMC page for the most updated AUM.

Regional Allocation:

LGI_US500_Stock_Index_Region.png

Sector Allocation:

LGI_US500_Stock_Index_Sector.png

Source: MorningStar as of 30 April 2021. Allocation data indicate actual exposure as a percentage of the Fund's total Net Asset Value. Please refer to the Fund Manager Page for the most updated information on Fund Holdings and Breakdown. 

Selection Criteria

Endowus has selected the LionGlobal Infinity Global Stock Index Fund as it allows for broad exposure to large and mid-cap companies in the United States, and gives investors, including CPF investors, the access to a low-cost, diversified portfolio of US equities. 

With the aim to replicate the S&P 500 Index as closely as possible, the Fund holds a portfolio of more than 500 names across large and mid-sized company stocks in the US (which is almost replicative of S&P 500 consisting of 500 companies), making it one of the most market-representative and diversified funds in the universe. The Fund is designed to deliver the benchmark’s return at the lowest cost possible, which is enabled by the manager’s wide presence around the world to facilitate efficient trading and index replication, and attempts to add value by anticipating index changes and trading changes one to two days before and after the change. The resulting portfolio is highly accurate and low-cost, and we expect investors to benefit from the exposure to global markets and achieve a cost-efficient return over the long term.

The Fund is managed by the team at Vanguard and wrapped by LionGlobal Investors for access to Singaporean investors, including CPF members -- we have enabled this by working hard with Vanguard and LionGlobal to include the Fund into CPFIS List A, as well as through our industry-first approach of rebating 100% of trailer fees back to our clients that brings the Fund TER within the CPF guidelines. With this, the Fund is one of the two only passive index funds available for CPF investing, and is available exclusively for CPF investing at Endowus (the other fund is the LionGlobal Infinity Global Stock Index Fund, which is also available exclusively on Endowus for CPF investing).

Additionally, the Fund is an Irish-domiciled UCITS fund which is more tax-efficient, and denominated in Singapore dollars to make an FX-efficient portfolio for investors based in Singapore, matching your assets with your future liabilities and removing unnecessary FX risk and cost. All in all, the Fund is another example of the continuous efforts made by Endowus to improve the risk-adjusted performance and cost-efficiency of our clients’ portfolios.

-----------------------------------

Updated by Endowus: June 2021

** Disclaimer
Past performance should not be taken as an indication or guarantee of future performance and no representation or warranty, express or implied, is made regarding future performance. Any opinions expressed reflect a judgment at the original date of publication by us and are subject to change without notice.

The prospectus, profile statement, product highlight sheet, fund factsheet or other offer or product documents may contain references about the expected risk tolerance of their target investors. These are in no way indicative of how we at Endowus have assessed your risk tolerance based on your stated objectives and financial situation. Endowus accepts no responsibility for investment decisions made in response to the expected risk tolerance levels mentioned in the product or offer documents.